TOP TIERMARKET NEWSWIRE
News & sentiment

SCRIBE THERAPEUTICS (SCTX) — News & AI sentiment

SCRIBE THERAPEUTICS (SCTX) news roundup. 16 stories aggregated over the last 30 days. Average 30-day sentiment is 55.4/100. Recent insider activity (SEC Form 4, 90-day window): 6 purchases totalling $71.3M and 0 sales totalling $0 — net buying of $71.3M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
16
avg sentiment 55.4/100
Insider net (90d)
$71.3M
6 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

SCTX news in the last 24 hours, 7 days, 30 days and 90 days

How much SCTX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowSCTX storiesAvg AI sentimentRead
Last 24 hours0no coverage
Last 7 days0no coverage
Last 30 days1655.4/100SCTX headlines →
Last 90 days3852/100SCTX headlines →

Latest stories on SCTX

Sep 2
Sep 2
Sep 2
Sep 2
Sep 2
Sep 1
Sep 1
Aug 31
Aug 18
Aug 18
Aug 18
Aug 18
Guggenheim initiates Scribe Therapeutics stock with buy rating
Investing.com Analyst Ratings61 · neutralanalyst
Aug 18
Aug 18
Scribe Therapeutics stock coverage initiated at Goldman Sachs
Investing.com Analyst Ratings56 · neutralanalyst
Aug 18
Aug 17
Jul 30
Jul 27
Jul 27
Jul 27
Scribe Therapeutics raises $155.51M in IPO on Nasdaq
Investing.com Markets24 · bearishgeneral
Jul 27
Jul 27
Why is Scribe Therapeutics stock surging today?
Investing.com Markets50 · neutralgeneral
Jul 24
Jul 24
Jul 24
Open SCTX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →